Wire · opportunities
Mayo Clinic, Thermo Fisher Launch Precure for Early Disease Biomarker Analysis
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 September 2026 · Fusion42 review
Mayo Clinic and Thermo Fisher Scientific have launched Precure LLC, a joint venture to integrate genomic, proteomic, and clinical data from one million biospecimens to detect early biological signals of diseases. This initiative aims to support earlier diagnosis, targeted treatments, and improved patient outcomes across diseases like cancer, cardiometabolic, neurological, and immune disorders through advanced AI and data analytics.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Your biotech firm can now explore partnerships or develop diagnostic tools using one of the largest combined clinical and molecular datasets available. Early detection and personalised treatment development can gain a boost from Precure's scale and data integration technology.
◆ Coverage
1 source · 18 Sep 2026
◆ Related on Wire
◆ Topics